Literature DB >> 2299739

Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland.

M L Pantelides1, C Whitehurst, J V Moore, T A King, N J Blacklock.   

Abstract

We are investigating the feasibility of photodynamic therapy in the treatment of localised prostatic cancer. Of major importance in this form of treatment is the extent to which light penetrates the target organ; hence, our interest in the optical properties of the human prostate gland. We obtained three whole prostates from autopsies of patients who died of non-urological causes. Red light was launched interstitially and detector fibres measured light intensity as a function of distance from the delivery fibre end. The optical constants derived from the three prostates were almost identical and indicated that light was predominantly scattered rather than absorbed (mean absorption and scattering coefficients 0.07 +/- 0.02 mm.-1 and 0.86 +/- 0.05 mm.-1 respectively). In a comparison of the tissue penetration by four different wavelengths, 633 nm red light was found to be transmitted best. Light propagation in the heavily absorbing tissue of the human liver was 4.3 times poorer than in the prostate. Such a combination of low absorption and high scattering characteristics in prostatic tissue would enhance the effectiveness of PDT. The optical constants derived will enable "light treatment planning" in patients with prostatic cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2299739     DOI: 10.1016/s0022-5347(17)39973-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Enhancement of tissue lesion depth by dual wavelength irradiation with the Nd-YAG/KTP laser: Perspectives for laser prostatectomy.

Authors:  F Schmidlin; G Delacrètaz; M Oswald; C Iselin; P Jichlinski; B Mermillod; R Lemoine; H J Leisinger; P Graber
Journal:  Lasers Med Sci       Date:  1997-12       Impact factor: 3.161

Review 2.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

Review 3.  The role of photodynamic therapy (PDT) physics.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

Review 4.  Photodynamic therapy for prostate cancer--a review of current status and future promise.

Authors:  Caroline M Moore; Doug Pendse; Mark Emberton
Journal:  Nat Clin Pract Urol       Date:  2009-01

5.  Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.

Authors:  Timothy C Zhu; Andreea Dimofte; Jarod C Finlay; Diana Stripp; Theresa Busch; Jeremy Miles; Richard Whittington; S Bruce Malkowicz; Zelig Tochner; Eli Glatstein; Stephen M Hahn
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

6.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Jarod C Finlay; Stephen M Hahn
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

7.  Vascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning.

Authors:  N Betrouni; S Boukris; F Benzaghou
Journal:  Lasers Med Sci       Date:  2017-06-01       Impact factor: 3.161

8.  Determination of optical properties in heterogeneous turbid media using a cylindrical diffusing fiber.

Authors:  Andreea Dimofte; Jarod C Finlay; Xing Liang; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2012-09-12       Impact factor: 3.609

9.  Separation of absorption and scattering properties of turbid media using relative spectrally resolved cw radiance measurements.

Authors:  Serge Grabtchak; William M Whelan
Journal:  Biomed Opt Express       Date:  2012-09-04       Impact factor: 3.732

Review 10.  Photodynamic therapy: a new approach to prostate cancer.

Authors:  Rolf Muschter
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.